IDENTIFICATION OF HUB BIOMARKERS AND THERAPEUTIC AGENTS FOR RENAL INTERSTITIAL FIBROSIS THROUGH BIOINFORMATICS ANALYSIS AND EXPERIMENTAL VALIDATION

WCN23-0692
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease Diagnosis, Classification and Progression
 
 
 
 
IDENTIFICATION OF HUB BIOMARKERS AND THERAPEUTIC AGENTS FOR RENAL INTERSTITIAL FIBROSIS THROUGH BIOINFORMATICS ANALYSIS AND EXPERIMENTAL VALIDATION
Li, J.(1)*;
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Peking Union Medical College Hospital, Nephrology, Beijing, China;
 
 
if any